K vs XGN · P/E 23, $29.03B cap vs rev $55.6M
Kellanova (K) versus Exagen Inc (XGN) — a side-by-side from cached financials, not a winner call.
Kellanova (K) is a packaged foods company listed on US.
Exagen Inc (XGN) is a diagnostics & research company listed on US.
K does not have a complete income-statement cache yet.
Latest reported XGN revenue for 2024-12-31 was $55.6M. Net income was -$15.1M. Revenue was up 5.9% from 2023-12-31 to 2024-12-31. XGN currently screens at market cap $154.1M.
K currently screens at market cap $29.03B and trailing P/E 22.8. XGN currently screens at market cap $154.1M.
Not investment advice. Open the K and XGN stock pages for the full models.
Not investment advice.